GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » SenesTech Inc (NAS:SNES) » Definitions » Debt-to-Equity

SenesTech (SenesTech) Debt-to-Equity : 0.06 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is SenesTech Debt-to-Equity?

SenesTech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.25 Mil. SenesTech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.16 Mil. SenesTech's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $6.35 Mil. SenesTech's debt to equity for the quarter that ended in Dec. 2023 was 0.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for SenesTech's Debt-to-Equity or its related term are showing as below:

SNES' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.55   Med: 0.07   Max: 0.37
Current: 0.06

During the past 10 years, the highest Debt-to-Equity Ratio of SenesTech was 0.37. The lowest was -0.55. And the median was 0.07.

SNES's Debt-to-Equity is ranked better than
83.77% of 1399 companies
in the Chemicals industry
Industry Median: 0.35 vs SNES: 0.06

SenesTech Debt-to-Equity Historical Data

The historical data trend for SenesTech's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SenesTech Debt-to-Equity Chart

SenesTech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.37 0.06 0.07 0.06

SenesTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.09 0.10 0.10 0.06

Competitive Comparison of SenesTech's Debt-to-Equity

For the Specialty Chemicals subindustry, SenesTech's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SenesTech's Debt-to-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, SenesTech's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where SenesTech's Debt-to-Equity falls into.



SenesTech Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

SenesTech's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

SenesTech's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SenesTech  (NAS:SNES) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


SenesTech Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of SenesTech's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


SenesTech (SenesTech) Business Description

Traded in Other Exchanges
N/A
Address
23460 N 19th Avenue, Suite 110, Phoenix, AZ, USA, 85027
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets.
Executives
Joel Lee Fruendt director, officer: Chief Executive Officer C/O SENESTECH, INC., 23460 N. 19TH AVE., STE 110, PHOENIX AZ 85027
Grandinetti Phillip Nicholas Iii director 23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Kathleen Claire Kavanagh director 23460 N. 19TH AVE SUITE 110, PHOENIX AZ 85027
Jamie Bechtel Morrison director 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Jacob Steven Leach director 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Delphine Francois Chiavarini director 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 86004
Kenneth S Siegel director, officer: Chief Executive Officer 40 STARWOOD HOTELS & RESORTS, 111 WESTCHESTER AVE, WHITE PLAINS NY 10604
Nicole C Williams officer: Chief Strategy Officer 23460 N 19TH AVE SUITE 110, PHOENIX AZ 85027
Steven C. Krause officer: EVP, Sales and Marketing 23460 N. 19TH AVE STE 110, PHOENIX AZ 85027
Loretta Powers Mayer director, 10 percent owner, officer: CEO & Chief Scientific Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Cheryl Ann Dyer director, 10 percent owner, officer: Pres. & Chief Research Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Edward Albe officer: SVP of Commercialization 3140 N. CADEN COURT SUITE 1, FLAGSTAFF AZ 96004
Julia Ann Williams director C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Andrew Altman officer: Chief Operating Officer C/O SENESTECH, INC., 3140 N. CADEN COURT, SUITE 1, FLAGSTAFF AZ 86004
Grover T Wickersham director, officer: Vice Chairman 430 CAMBRIDGE AVENUE, SUITE 100, PALO ALTO CA 94306